Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Next leg up coming people want in before the weekend been waiting for a dip all day there hasn't been one nobody wants to give up shares
With this float we could run to dollar land easily
Just make sure to load before the weekend. Monday we go parabolic
50 cents this monday 2 dollars next monday mark this post
Last chance to get in under 7 here
$LGNDZ just getting started next 100% leg up coming soon impending squeeze of doom float is locked and we havnt even gotten started enjoy the ride everyone
Nobody wants to sell at those bid prices rhats how you know we have something th is is gonna be the gap and run of 2020 on monday after everyone has the weekend to see us on the breakout board
This moves on so little volume does anyone know the share structure
People must be still figuring this out .. we should spread the word.. monday with volume we go .50 to 1.00. This is the easiest money I've ever made
Omg Lgndz AMAZING MONSTER RUNNER!!!
Lost 45000 shares trying to flip there
Whoever shorted those shares the profit takers sold end of day is probably gonna have a real bad day tomorrow csnt ignore the gap... and with nothing to scare people they have to make up their own to scare people
The ask is still super thin there just isn't much pressure now cause its late in the day and we are already up close to 175% tomorrow morning with pressure should see .05 potentially and .35 to multi dollars depending how things play out in the coming weeks/months
Can't be impatient though. A little slower run up is healthy cant expect 400 % every day
Tomorrow will be the blast off 2 days of 100% plus gains with no correction tomorrow run nobody will be able to doubt or call a scam
Look at the gap float is locked
It's very difficult to flip this stock demand is insane they cant hold it back
if we increase 100 % a day for 3 days we are at .33 cents per share
im going to continue pressure with small buys on the ask. it's more about pressure ritght now than timing, we can make this go as high as we want float is just about locked up
Gap and run every day now, NSPX super healthy, no good for flippers anymore. should get rid of some of the negativity here as well. except for the fact there will be alot of disgruntled traders that got caught in the short sqeeze. so they may try to come here and bash us. you know how jelousy is.
here we go pressure at the high of the day shorts cover and off to the moon
i love watching shorts lose money. they usually have the advantage until they dont'.. then it's real bad for them they could lose everything on this
any buy pressure on the ask sends this thing soaring
ive never seen this kind of demand for a penny stock in 20 years of trading
same way the 400 % run started on thursday
thank god i got in before the weekend, market senses green there is no catching this now
straight back up after shorts covered its gap and run for sure
shorts scared covering already
save your large buys until a dip to squeeze the shorts
we won't get gap trapped, they will. i'm going to slap the ask on the first dip big, all who can should join me and we will sqeeze them to death
To put it in simple terms anyone can understand gilead has patent x with value y this values reflect in their stock price. When they lost orphan status the value of the patent becomes split between gilead and all the generics. So you take
gileads post news corrected market cap dand divide that by the number of company's holding patents for a generic.
And this is now fact no it is no longer speculation. I believe they will take thr price up slow or try to but it may honestly be hard to hold this back at this point. This is indeed a perfect storm of momentum, fundamentals and an extreme situation creating a massive demand for their product a demand so great.befoew covid 19 it couldn't even be conceived
What people don't realize is that before covid-19 The value of their patent wasn't much because the drug was for a rare condition Once it was found that it can be used for a disease that affects literally the entire world and could save lives the value would have been immediately realized if not for Gilead's orphan drug exception. However what may nOt have clicked for investors yet possibly in part to the hype. Is that just before market close on friday gilead lost orphan drug status. So as of Friday after Gilead's statement the value of the patent is no longer theoretical. So no amount of news or lack of news will stop nspx stock price from correcting to reflect the new value of a patent for a GENERIC drug that everybpdy in the world needs. Remember most people buy generic not name brand. So these sales will become actual profits that are no longer theoretical or speculators. The fact the company has not released a PR and only dropped subtle hints alone is proof they are legit. Legit company's dont have any need to pump their stock.
That means that analyst that projected 21 dollars per share works for WSJ and CNN and they both published those projections. Those seem like pretty reputable sources in the business world I dont think they would risk their reputation on a pump nor have any need to. Think about it. Besides all this covid 19 stuff they had been working heavily with chrons disease and had plans to become profitable again well before they ever knew they had a patent for a generic drug GENERIC that people will need millions of and gilead will have no chance to corner the market they will produce billions of pills
WSJ rates nspx a buy currently with target price over 21 dollars per share https://www.wsj.com/market-data/quotes/NSPX/research-ratings see for yourself and the rating was changed to buy only this month
Inspyre therapeutics mentioned in this news article March 6th https://finance.yahoo.com/amphtml/news/crohns-disease-2020-pipeline-review-150600425.html